Dove Medical Press requires that the authors use the generic (non-proprietary) name of a drug throughout a manuscript whenever possible. The authors should give the chemical name or formula when a drug does not have a generic name. If this isn’t possible, for example for complex formulations, a drug can be identified by the trade name as appropriate and the trade name used subsequently. The active ingredients should be specified in the text after the first use of the trade name.
In the United States, check generic names in the American Drug Index, Merck Index, United States Pharmacopeia (USP), Physician’s Desk Reference, National Formulary, or United States Adopted Names (USAN), In the United Kingdom, the authors should refer to http://medicines.mhra.gov.uk.
When the use of a trade name is necessary, the authors should place the trade name in parentheses immediately after the first mention of the generic name.
If an alternative generic name and a trade name are used, both may appear in parentheses at first mention.
When the salt is included in both the generic name and the trade name, it should only be given once.
The authors should capitalize trade names and should not use the registered trademark symbol.
Updated 18 September 2017